VIRAX BIOLABS GROUP LTD (VRAX) Stock Price, Quote, News and Overview
NASDAQ:VRAX - Nasdaq - KYG9495L1251 - Common Stock - Currency: USD
VRAX Quote, Performance and Key Statistics
VIRAX BIOLABS GROUP LTD
NASDAQ:VRAX (1/31/2025, 8:00:02 PM)
After market: 1.7 +0.01 (+0.59%)1.69
0 (0%)
The current stock price of VRAX is 1.69 USD. In the past month the price decreased by -24.89%. In the past year, price increased by 111.25%.
VRAX Latest News, Press Releases and Analysis
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
VRAX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 20.6 | 75.50B | ||
| COR | CENCORA INC | 18.47 | 49.13B | ||
| CAH | CARDINAL HEALTH INC | 16 | 29.93B | ||
| HSIC | HENRY SCHEIN INC | 19 | 9.97B | ||
| PDCO | PATTERSON COS INC | 14.6 | 2.73B | ||
| AHCO | ADAPTHEALTH CORP | N/A | 1.46B | ||
| OMI | OWENS & MINOR INC | 8.58 | 1.10B | ||
| AHG | AKSO HEALTH GROUP | N/A | 510.49M | ||
| COSM | COSMOS HEALTH INC | N/A | 16.47M | ||
| ATPC | AGAPE ATP CORP | N/A | 5.59M |
Related stock screener links
About VRAX
Company Profile
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Company Info
VIRAX BIOLABS GROUP LTD
Biocity Glasgow, Bo'ness Road, Newhouse
London GB
Employees: 17
Company Website: https://www.viraxbiolabs.com
Investor Relations: https://ir.viraxbiolabs.com/
Phone: 4402077887414
VRAX FAQ
What is the stock price of VRAX?
The current stock price of VRAX is 1.69 USD.
What is the symbol for VIRAX BIOLABS GROUP LTD stock?
The exchange symbol of VIRAX BIOLABS GROUP LTD is VRAX and it is listed on the Nasdaq exchange.
On which exchange is VRAX stock listed?
VRAX stock is listed on the Nasdaq exchange.
Is VRAX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VRAX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VRAX.
Does VRAX stock pay dividends?
VRAX does not pay a dividend.
When does VRAX stock report earnings?
VRAX will report earnings on 2022-12-13, before the market open.
What is the Price/Earnings (PE) ratio of VRAX?
VRAX does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.6).
What is the Short Interest ratio of VRAX stock?
The outstanding short interest for VRAX is 4.07% of its float.
VRAX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to VRAX. When comparing the yearly performance of all stocks, VRAX is one of the better performing stocks in the market, outperforming 91.72% of all stocks.
VRAX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VRAX. While VRAX seems to be doing ok healthwise, there are quite some concerns on its profitability.
VRAX Financial Highlights
Over the last trailing twelve months VRAX reported a non-GAAP Earnings per Share(EPS) of -2.6. The EPS decreased by 34.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.69% | ||
| ROE | -76.12% | ||
| Debt/Equity | 0.06 |
VRAX Ownership and Analysts
For the next year, analysts expect an EPS growth of 68.42% and a revenue growth 477.17% for VRAX